rs876657785
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PVS1_Strong
The NM_014908.4(DOLK):c.196C>T(p.Gln66*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,726 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. Q66Q) has been classified as Likely benign.
Frequency
Consequence
NM_014908.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- DK1-congenital disorder of glycosylationInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, G2P
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DOLK | NM_014908.4 | c.196C>T | p.Gln66* | stop_gained | Exon 1 of 1 | ENST00000372586.4 | NP_055723.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461726Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727182 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. The p.Gln66X va riant in DOLK has not been previously reported in individuals with cardiomyopath y and was absent from large population studies. This nonsense variant leads to a premature termination codon at position 66. Because this gene contains only a s ingle exon, this alteration is more likely to escape nonsense mediated decay (NM D) and result in a truncated protein. It is unclear how this alteration will imp act the protein's function. Studies on previously reported DOLK variants suggest that reduced protein function is disease-causing. However, there is limited inf ormation on the variant spectrum of this gene and the significance of truncating variants or complete loss of protein function remain unclear. In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Gln66X variant is uncertain. -
DK1-congenital disorder of glycosylation Uncertain:1
This sequence change creates a premature translational stop signal (p.Gln66*) in the DOLK gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 473 amino acid(s) of the DOLK protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DOLK-related conditions. ClinVar contains an entry for this variant (Variation ID: 228618). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at